Results 201 to 210 of about 22,015 (248)

Does the Korean economy depend too much on Samsung? [PDF]

, 2015
Kim, Hyoung Tae
core  

Effectiveness and safety of adalimumab biosimilar in bio-naive patients with inflammatory bowel disease: a real-life multicenter observational study comparing ABP501, SB5, MSB11022, GP2017, and FKB327. [PDF]

Crohns Colitis 360
Regueiro C, Vázquez Rey MT, Bastón-Rey I, Galego MA, Campos AC, Baz López AM, Arriero GM, Ruiz Barcia MJ, Villaamil PV, EIGA.   +9 more
europepmc   +1 more source

Anti-VEGF Therapies in Retinal Disorders: Current Landscape and Future Directions. [PDF]

Clin Ophthalmol
Sheth JU.
europepmc   +1 more source

Regulierung und adäquate Preisbildung im Markt der Biosimilars: Projekt im Auftrag der Pfizer Deutschland GmbH

, 2017
Altin, Sibel, Bauer, Cosima, May, Uwe, Walendzik, Anke, Wasem, Jürgen, Ziebe, Anissa   +5 more
core  

Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report. [PDF]

SAGE Open Med Case Rep
Lozito A, Baravalle S, Poddine G, Colato C, Carletto A, Fracassi E, Bellinato F, Girolomoni G, Gisondi P.   +8 more
europepmc   +1 more source

Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety. [PDF]

Adv Ther
Schmalzing M, Askari A, Girolomoni G, Perez-Coleman JCV, Salvati C, Bachinskaya E.   +5 more
europepmc   +1 more source

Phase III Study to Confirm Clinical Similarity of MB09, a Denosumab Biosimilar, and Prolia^® in Postmenopausal Women with Osteoporosis (SIMBA Study). [PDF]

Pharmaceutics
Supronik J, Giorgadze E, Blicharski T, Sánchez-Vidaurre S, Pérez-Díaz L, Paravisini A, Millán S.   +6 more
europepmc   +1 more source

Regulatory Requirements for Interchangeable Biosimilar Designation. [PDF]

Ther Innov Regul Sci
Samy PJ, Mouslim MC, Bennett CL, Trujillo AJ.   +3 more
europepmc   +1 more source

HASH(0x563d440b87b0) [PDF]

, 2007
Groth, S.
core